Evidence method
Level · gp.fundamentals.debt_to_revenue
104.37% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TECH · Mar 31, 2025
BIO-TECHNE Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-25-006990General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.01% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
4.20% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
60.43% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.86% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
12.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.60% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 101.00%
- Current
- 104.37%
- Delta
- 3.37%
- Previous
- 2.30%
- Current
- 3.20%
- Delta
- 0.91%
- Previous
- 28.40%
- Current
- 13.01%
- Delta
- -15.39%
- Previous
- 8.96%
- Current
- 4.20%
- Delta
- -4.76%
- Previous
- 63.42%
- Current
- 60.43%
- Delta
- -2.98%
- Previous
- 65.27%
- Current
- 67.86%
- Delta
- 2.58%
- Previous
- 15.96%
- Current
- 12.24%
- Delta
- -3.72%
- Previous
- 4.95%
- Current
- 3.60%
- Delta
- -1.35%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TECH Fundamental State →Has State · BIO-TECHNE Corp →Transitioned To · TECH Fundamental State →Transitioned To · TECH BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · TECH CAPEX_INTENSITY_INCREASED →Transitioned To · TECH CASH_GENERATION_DECREASED →Transitioned To · TECH GROWTH_DECREASED →Transitioned To · TECH INVENTORY_PRESSURE_DECREASED →Transitioned To · TECH MARGIN_INCREASED →Transitioned To · TECH PROFITABILITY_DECREASED →Transitioned To · TECH SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.